Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Update of the drug resistance mutations in HIV-1: 2004.
Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD. Johnson VA, et al. Among authors: schapiro jm. Top HIV Med. 2004 Oct-Nov;12(4):119-24. Top HIV Med. 2004. PMID: 15516709 Free article. Review. No abstract available.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Tural C, Ruiz L, Holtzer C, Schapiro J, Viciana P, González J, Domingo P, Boucher C, Rey-Joly C, Clotet B; Havana Study Group. Tural C, et al. AIDS. 2002 Jan 25;16(2):209-18. doi: 10.1097/00002030-200201250-00010. AIDS. 2002. PMID: 11807305 Clinical Trial.
Drug Resistance Mutations in HIV-1.
D'Aquila RT; International AIDS Society-USA; Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD. D'Aquila RT, et al. Among authors: schapiro jm. Top HIV Med. 2002 Nov-Dec;10(5):21-25. Top HIV Med. 2002. PMID: 12717052 Free article. No abstract available.
HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms.
Ravela J, Betts BJ, Brun-Vézinet F, Vandamme AM, Descamps D, van Laethem K, Smith K, Schapiro JM, Winslow DL, Reid C, Shafer RW. Ravela J, et al. Among authors: schapiro jm. J Acquir Immune Defic Syndr. 2003 May 1;33(1):8-14. doi: 10.1097/00126334-200305010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12792349 Free PMC article.
Drug resistance mutations in HIV-1.
D'Aquila RT, Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD. D'Aquila RT, et al. Among authors: schapiro jm. Top HIV Med. 2003 May-Jun;11(3):92-6. Top HIV Med. 2003. PMID: 12837968 Free article. No abstract available.
Drug resistance mutations in HIV-1.
Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD; International AIDS Society-USA Drug Resistance Mutations Group. Johnson VA, et al. Among authors: schapiro jm. Top HIV Med. 2003 Nov-Dec;11(6):215-21. Top HIV Med. 2003. PMID: 14724329 Free article. Review.
Clinically validated genotype analysis: guiding principles and statistical concerns.
Brun-Vézinet F, Costagliola D, Khaled MA, Calvez V, Clavel F, Clotet B, Haubrich R, Kempf D, King M, Kuritzkes D, Lanier R, Miller M, Miller V, Phillips A, Pillay D, Schapiro J, Scott J, Shafer R, Zazzi M, Zolopa A, DeGruttola V. Brun-Vézinet F, et al. Antivir Ther. 2004 Aug;9(4):465-78. Antivir Ther. 2004. PMID: 15456077 Review.
Updated European recommendations for the clinical use of HIV drug resistance testing.
Vandamme AM, Sönnerborg A, Ait-Khaled M, Albert J, Asjo B, Bacheler L, Banhegyi D, Boucher C, Brun-Vézinet F, Camacho R, Clevenbergh P, Clumeck N, Dedes N, De Luca A, Doerr HW, Faudon JL, Gatti G, Gerstoft J, Hall WW, Hatzakis A, Hellmann N, Horban A, Lundgren JD, Kempf D, Miller M, Miller V, Myers TW, Nielsen C, Opravil M, Palmisano L, Perno CF, Phillips A, Pillay D, Pumarola T, Ruiz L, Salminen M, Schapiro J, Schmidt B, Schmit JC, Schuurman R, Shulse E, Soriano V, Staszewski S, Vella S, Youle M, Ziermann R, Perrin L. Vandamme AM, et al. Antivir Ther. 2004 Dec;9(6):829-48. Antivir Ther. 2004. PMID: 15651743
Update of the Drug Resistance Mutations in HIV-1: 2005.
Johnson VA, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, Pillay D, Schapiro J, Telenti A, Richman D. Johnson VA, et al. Top HIV Med. 2005 Mar-Apr;13(1):51-7. Top HIV Med. 2005. PMID: 15849371 Free article. Review.
143 results